Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

5
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
5
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

152
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
152
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

132
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
132
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.1K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

113
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Human Genetics01:28

Human Genetics

1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic regulation of insulin resistance surrogate index (TyG) and susceptibility to common diseases based on phenome-wide association study.

Molecular and cellular biochemistryĀ·2026
Same author

Plasma Exosomal miR-106b-5p Is Associated With Osteoporosis by Targeting <i>SMAD5, BMP2</i>, and <i>MAPK1</i> Genes.

In vivo (Athens, Greece)Ā·2026
Same author

Plasma exosomal miR-181a-5p is linked to osteoporosis by mediating endothelial-osteoblast crosstalk and regulating bone remodeling.

Biochemical and biophysical research communicationsĀ·2026
Same author

Identification and Validation of a Machine Learning Predictive Model for Type 2 Diabetes Mellitus Based on Inflammation-Related Indicators.

Population health managementĀ·2025
Same author

Diversity of Multicellular Magnetotactic Prokaryotes in Sanya Haitang Bay.

MicroorganismsĀ·2025
Same author

Facial skin aging is a potential osteoporosis-associated marker: evidence from both observational and genetic studies.

Journal of bone and mineral metabolismĀ·2025
Same journal

Genotype-phenotype correlations in autoimmune and autoinflammatory diseases: An NGS-based immunogenetic cohort study.

ImmunogeneticsĀ·2026
Same journal

Elevated interleukin-36Ī³ and gene polymorphisms implicate novel risk in essential hypertension.

ImmunogeneticsĀ·2026
Same journal

Unraveling the genomic structures, conserved functional domains and evolutionary dynamics of beta-defensins in Bubalus bubalis and Ovis aries.

ImmunogeneticsĀ·2026
Same journal

Genetic characterization of the TAPBP and its allelic association with BF2 in the chicken major histocompatibility complex.

ImmunogeneticsĀ·2026
Same journal

Reconstructed amphibian heavy-chain constant regions support a mosaic origin of IgXA with IgY-like CH1-CH2, an intermediate CH3, and an IgM-like CH4.

ImmunogeneticsĀ·2026
Same journal

Climate factors and selection shape MHC class II diversity in a montane wild sheep (Ovis ammon).

ImmunogeneticsĀ·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.5K

Functional relevance for multiple sclerosis-associated genetic variants.

Xiang Lin1, Fei-Yan Deng, Xing-Bo Mo

  • 1Center for Genetic Epidemiology and Genomics, School of Public Health, Soochow University, Suzhou, 215123, Jiangsu, People's Republic of China.

Immunogenetics
|October 14, 2014
PubMed
Summary
This summary is machine-generated.

This study identifies specific genetic variants linked to multiple sclerosis (MS). Functional analyses reveal how these single nucleotide polymorphisms (SNPs) impact gene expression, offering new insights into MS pathogenesis.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Related Experiment Videos

Last Updated: Apr 22, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.5K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Area of Science:

  • Genetics
  • Neuroimmunology
  • Computational Biology

Background:

  • Multiple sclerosis (MS) is a central nervous system inflammatory and demyelinating disease.
  • Genome-wide association studies have identified numerous MS-associated genetic variants, but their functional mechanisms remain largely unknown.

Purpose of the Study:

  • To investigate the functional relevance of MS-associated single nucleotide polymorphisms (SNPs).
  • To identify specific SNPs and their target genes that may contribute to MS pathogenesis.
  • To explore the molecular mechanisms underlying genetic associations in MS.

Main Methods:

  • Utilized Gene Relationships Among Implicated Loci (GRAIL) analysis on public datasets to identify MS-associated SNPs and genes.
  • Performed expression quantitative trait loci (eQTL) analyses to link SNPs with target gene regulation.
  • Conducted functional predictions for SNPs, differential gene expression analysis, and functional annotation clustering for genes.

Main Results:

  • Identified 284 MS-associated SNPs (P < 10^-4), with 45 acting as cis-regulators for 19 MS-associated genes via eQTL analysis.
  • Found 14 of the 19 eQTL target genes exhibited significantly differential expression in MS-related cells.
  • Predicted 15 SNPs in transcription factor binding sites, with six SNPs (rs3095329, rs9469220, rs2647046, rs11154801, rs1062158, rs7194) showing functional relevance to MS through gene expression or microRNA binding.

Conclusions:

  • The study highlights the functional significance of six specific SNPs in the context of multiple sclerosis.
  • These findings provide novel insights into the functional mechanisms of MS-associated genetic variants.
  • Improved understanding of MS genetic associations through the identification of functionally relevant SNPs and their regulatory roles.